MedTrace Logo

Prenatal Exposure to Emerging Contaminants and Children's Atopic Dermatitis

NCT06316609 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 456

Last updated 2026-05-15

No results posted yet for this study

Summary

This prospective cohort study aims to investigate the association between prenatal blood levels of Emerging Contaminants and the five-year incidence of atopic dermatitis (AD) in offspring.

Conditions

Interventions

OTHER

Gestational Exposure to Emerging Contaminants (ECs)

Levels of Emerging Contaminants (ECs), such as Per- and Polyfluoroalkyl Substances (PFASs), Organophosphate Flame Retardants (OPFRs), and Microplastics, are assessed in maternal blood and umbilical cord blood during gestation.

Sponsors & Collaborators

  • Minhang Maternal and Children Health Care Hospital

    collaborator OTHER

  • School of Public Health，Fudan University

    collaborator UNKNOWN

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Ying Ye, MD,PhD · Children's Hospital of Fudan University Shanghai, China, 201102

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-04-30
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06316609 on ClinicalTrials.gov